CEFTRIAXONE in NS recalled over sterility concerns
- Recall date
- September 18, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Sentara Enterprises recalls CEFTRIAXONE in NS, Packaged as a) 1GM in 50ML Homepumps, b) 2GM in 100ML Homepumps, and c) 8GM in 200ML Homepumps, Rx O…
- Recall number
- D-0621-2016
- FDA classification
- Class II
- Brand / firm
- Sentara Enterprises
- Sold / distributed
- U.S. Including: VA, NC
Why it was recalled
Lack of Assurance of Sterility: Product sterility cannot be guaranteed.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
CEFTRIAXONE in NS, Packaged as a) 1GM in 50ML Homepumps, b) 2GM in 100ML Homepumps, and c) 8GM in 200ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.
Get recall alerts
Free email alert whenever Sentara Enterprises has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Sentara Enterprises